Old Web
English
Sign In
Acemap
>
Paper
>
Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification
Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification
2021
Michael D. Nissen
Xuehai Wang
Clémentine Sarkozy
Aixiang Jiang
Daisuke Ennishi
Tomohiro Aoki
Stacy Hung
Elizabeth A. Chavez
Jeffrey W. Craig
Pedro Farinha
Graham W. Slack
David Scott
Christian Steidl
Andrew P. Weng
Keywords:
risk stratification
Cancer research
immune profiling
Cell of origin
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]